Erdem & Erdem Advised İş Private Equity on the Enlila Biotechnology Initiative
We are proud to announce that Erdem & Erdem has advised İş Private Equity on the launch of Enlila, a biotechnology venture established to advance the innovative research led by Prof. Gökhan Hotamışlıgil at Harvard University.
Enlila is dedicated to transforming scientific discoveries into therapeutic solutions for unmet medical needs, including obesity and age-related diseases.
This initiative reflects Türkiye’s strong potential in the field of health technologies and underscores our commitment to creating long-term value through science, innovation, and entrepreneurship.
We are proud to support İş Private Equity in this Türkiye-based initiative, which brings to life a treatment with global application potential. We congratulate all stakeholders involved.
All rights of this article are reserved. This article may not be used, reproduced, copied, published, distributed, or otherwise disseminated without quotation or Erdem & Erdem Law Firm's written consent. Any content created without citing the resource or Erdem & Erdem Law Firm’s written consent is regularly tracked, and legal action will be taken in case of violation.